Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/18222
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Anticholesteremic Agents/*therapeutic use,Clinical Trials as Topic,Gemfibrozil/therapeutic use,Humans,Lovastatin/*therapeutic use,Myocardial Ischemia/*prevention & control,Pravastatin/*therapeutic use,Risk Factors,Simvastatin/*therapeutic use,Smoking/*adverse effects
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/18222
ISSN: 0003-3197
Link: http://www.ncbi.nlm.nih.gov/pubmed/11570656
http://ang.sagepub.com/content/52/9/575.full.pdf
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Milionis-2001-Smoking diminishes t.pdf860.56 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons